ANPEP
Aminopeptidase N
Also known as: AMPN_HUMAN, AP-N, CD13, gp150, hAPN, LAP1, p150, PEPN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15144
- Gene
- ANPEP
- Ensembl
- ENSG00000166825
- Chromosome
- 15
- Canonical length
- 967 aa
- Protein class
- CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Aminopeptidase N is located in the small-intestinal and renal microvillar membrane, and also in other plasma membranes. In the small intestine aminopeptidase N plays a role in the final digestion of peptides generated from hydrolysis of proteins by gastric and pancreatic proteases. Its function in proximal tubular epithelial cells and other cell types is less clear. The large extracellular carboxyterminal domain contains a pentapeptide consensus sequence characteristic of members of the zinc-binding metalloproteinase superfamily. Sequence comparisons with known enzymes of this class showed that CD13 and aminopeptidase N are identical. The latter enzyme was thought to be involved in the metabolism of regulatory peptides by diverse cell types, including small intestinal and renal tubular epithelial cells, macrophages, granulocytes, and synaptic membranes from the CNS. This membrane-bound zinc metalloprotease is known to serve as a receptor for the HCoV-229E alphacoronavirus as well as other non-human coronaviruses. This gene has also been shown to promote angiogenesis, tumor growth, and metastasis and defects in this gene are associated with various types of leukemia and lymphoma. [provided by RefSeq, Apr 2020]
Canonical amino-acid sequenceUniProt
967 residues, UniProt reviewed canonical sequence.
>P15144|ANPEP
1 MAKGFYISKS LGILGILLGV AAVCTIIALS VVYSQEKNKN ANSSPVASTT PSASATTNPA
61 SATTLDQSKA WNRYRLPNTL KPDSYRVTLR PYLTPNDRGL YVFKGSSTVR FTCKEATDVI
121 IIHSKKLNYT LSQGHRVVLR GVGGSQPPDI DKTELVEPTE YLVVHLKGSL VKDSQYEMDS
181 EFEGELADDL AGFYRSEYME GNVRKVVATT QMQAADARKS FPCFDEPAMK AEFNITLIHP
241 KDLTALSNML PKGPSTPLPE DPNWNVTEFH TTPKMSTYLL AFIVSEFDYV EKQASNGVLI
301 RIWARPSAIA AGHGDYALNV TGPILNFFAG HYDTPYPLPK SDQIGLPDFN AGAMENWGLV
361 TYRENSLLFD PLSSSSSNKE RVVTVIAHEL AHQWFGNLVT IEWWNDLWLN EGFASYVEYL
421 GADYAEPTWN LKDLMVLNDV YRVMAVDALA SSHPLSTPAS EINTPAQISE LFDAISYSKG
481 ASVLRMLSSF LSEDVFKQGL ASYLHTFAYQ NTIYLNLWDH LQEAVNNRSI QLPTTVRDIM
541 NRWTLQMGFP VITVDTSTGT LSQEHFLLDP DSNVTRPSEF NYVWIVPITS IRDGRQQQDY
601 WLIDVRAQND LFSTSGNEWV LLNLNVTGYY RVNYDEENWR KIQTQLQRDH SAIPVINRAQ
661 IINDAFNLAS AHKVPVTLAL NNTLFLIEER QYMPWEAALS SLSYFKLMFD RSEVYGPMKN
721 YLKKQVTPLF IHFRNNTNNW REIPENLMDQ YSEVNAISTA CSNGVPECEE MVSGLFKQWM
781 ENPNNNPIHP NLRSTVYCNA IAQGGEEEWD FAWEQFRNAT LVNEADKLRA ALACSKELWI
841 LNRYLSYTLN PDLIRKQDAT STIISITNNV IGQGLVWDFV QSNWKKLFND YGGGSFSFSN
901 LIQAVTRRFS TEYELQQLEQ FKKDNEETGF GSGTRALEQA LEKTKANIKW VKENKEVVLQ
961 WFTENSKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANPEP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 2,245 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 2,245 nTPM
- small intestine: 1,857 nTPM
- pancreas: 644 nTPM
- liver: 256 nTPM
- colon: 251 nTPM
- kidney: 236 nTPM
Single-cell type
- enterocytes: 6,495 nCPM
- pancreatic acinar cells: 711 nCPM
- enteric transient amplifying cells: 526 nCPM
- neutrophils: 454 nCPM
- colonocytes: 454 nCPM
- monocytes: 416 nCPM
Immune cell
- neutrophil: 228 nTPM
- classical monocyte: 56 nTPM
- non-classical monocyte: 50 nTPM
- eosinophil: 41 nTPM
- intermediate monocyte: 27 nTPM
- myeloid DC: 26 nTPM
Brain region
- thalamus: 39 nTPM
- cerebral cortex: 19 nTPM
- choroid plexus: 5.5 nTPM
- pons: 3.7 nTPM
- amygdala: 1.5 nTPM
- basal ganglia: 1.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ANPEP.
Disease | AutoantibodyPubMed
Conditions in which antibodies against ANPEP are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for ANPEP from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
8 publications
- Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease.
1996 · Transplantation · RCR 1.9 · 74 citations - CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients.
1996 · Transplantation · RCR 1.3 · 48 citations - A novel mechanism for virus-induced autoimmunity in humans.
1996 · Immunol Rev · RCR 0.9 · 36 citations - Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's disease.
2006 · J Autoimmun · RCR 0.9 · 32 citations - Clonal CD5-positive B lymphocytes in myelodysplastic syndrome with systemic vasculitis and trisomy 8.
1997 · Ann Hematol · RCR 0.5 · 16 citations
Show 3 more
- CD13/aminopeptidase N and murine cytomegalovirus infection.
2005 · Virology · RCR 0.3 · 11 citations - CD13 Autoantibodies Are Elevated in Sera From Mothers of Infants With Neonatal Cholestasis of Different Causes.
2017 · J Pediatr Gastroenterol Nutr · RCR 0.1 · 2 citations - [Clinical and hematological significance of antigranulocyte autoantibodies].
1998 · Klin Lab Diagn
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.43
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- alanyl aminopeptidase activity
- aminopeptidase activity
- metalloaminopeptidase activity
- metallopeptidase activity
- signaling receptor activity
- virus receptor activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase M1, alanine aminopeptidase/leukotriene A4 hydrolase
- Peptidase M1, membrane alanine aminopeptidase
- ERAP1-like C-terminal domain
- Peptidase M4/M1, CTD superfamily
- Aminopeptidase N-type
- Aminopeptidase N-like , N-terminal domain superfamliy
- Aminopeptidase N-like , N-terminal domain
- Peptidase M1 family aminopeptidases
- Peptidase family M1 domain
- ERAP1-like C-terminal domain
- Peptidase M1 N-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ANPEP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANPEP as an antibody target. Whether an autoantibody or antibody against ANPEP could matter depends on whether native ANPEP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANPEP is annotated at the cell surface, where native ANPEP is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ANPEP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...